Apolipoprotein E ε2 does not increase risk of early-onset sporadic Alzheimer's disease

W. K SCOTT; A. M SAUNDERS; P. C GASKELL; P. A LOCKE; J. H GROWDON; L. A FARRER; S. A AUERBACH; A. D ROSES; J. L HAINES; M. A PERICAK-VANCE

doi:10.1002/ana.410420317

Back

Apolipoprotein E ε2 does not increase risk of early-onset sporadic Alzheimer's disease

Conference proceeding

Peer reviewed

Apolipoprotein E ε2 does not increase risk of early-onset sporadic Alzheimer's disease

W. K SCOTT, A. M SAUNDERS, P. C GASKELL, P. A LOCKE, J. H GROWDON, L. A FARRER, S. A AUERBACH, A. D ROSES, J. L HAINES and M. A PERICAK-VANCE

Annals of neurology, Vol.42(3), pp.376-378

American Neurological Association. Annual Meeting

1997

DOI: https://doi.org/10.1002/ana.410420317

Abstract

Neurology

Biological and medical sciences

Medical sciences

Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases

Metrics

6 Record Views

18 Times Cited - Web of Science

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types: Domestic collaboration
Citation topics: 1 Clinical & Life Sciences; 1.52 Neurodegenerative Diseases; 1.52.57 Alzheimer's Disease
Web Of Science research areas: Clinical Neurology; Neurosciences
ESI research areas: Neuroscience & Behavior

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

Source: InCites

Details

Title: Apolipoprotein E ε2 does not increase risk of early-onset sporadic Alzheimer's disease
Creators: W. K SCOTT - Section of Medical Genetics, Duke University Medical Center, Durham, NC, United States
A. M SAUNDERS - Division of Neurology, Department of Medicine, Duke University Medical Center, Durham, NC, United States
P. C GASKELL - Section of Medical Genetics, Duke University Medical Center, Durham, NC, United States
P. A LOCKE - Molecular Neurogenetics Unit, Massachusetts General Hospital, Charlestown, United States
J. H GROWDON - Department of Neurology, Massachusetts General Hospital, Charlestown, United States
L. A FARRER - Department of Neurology, Boston University School of Medicine, Boston, MA, United States
S. A AUERBACH - Department of Neurology, Boston University School of Medicine, Boston, MA, United States
A. D ROSES - Division of Neurology, Department of Medicine, Duke University Medical Center, Durham, NC, United States
J. L HAINES - Molecular Neurogenetics Unit, Massachusetts General Hospital, Charlestown, United States
M. A PERICAK-VANCE - Section of Medical Genetics, Duke University Medical Center, Durham, NC, United States
Publication Details: Annals of neurology, Vol.42(3), pp.376-378
Conference: American Neurological Association. Annual Meeting
Publisher: Willey-Liss
Grant note: American Neurological Association
Academic Unit: Miller School of Medicine; John P. Hussman Institute for Human Genomics; UMMG Dept of Human Genetics - Clinical and Translational Genetics; UMMG Dept of Human Genetics (Dr. John T. Macdonald Foundation)
Language: English
Resource Type: Conference proceeding
Record Identifier: 991031600204202976